Melasma
Conditions
Keywords
Melasma, Dark spots on the face
Brief summary
This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with 20-30% salicylic acid every two weeks for a total of 4 peels. The first two peels will be 20% salicylic acid and the second two peels will be with 30% salicylic acid. The purpose of the study will be to evaluate the safety and efficacy of salicylic acid combined with 4% hydroquinone versus 4% hydroquinone alone.
Interventions
Two 20% salicylic acid peels two weeks apart followed by 2 30% salicylic acid peels two weeks apart to the right side of the face.
Two 20% salicylic acid peels two weeks apart followed by 2 30% salicylic acid peels two weeks apart to the left side of the face
Sponsors
Study design
Eligibility
Inclusion criteria
* Hispanic women ages 18-65 years of age with moderate to severe melasma * English and Spanish-speaking women
Exclusion criteria
* Pregnant or breast-feeding women * Subjects who have used 4% hydroquinone within 3 months of study start * Subjects who have used chemical peels, microdermabrasion or facial laser treatments within 9 months of study start
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Showing Improvement of Melasma Based on Mexameter Readings | 14 weeks | Improvement of melasma on the peel side using mexameter reading |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| 20% to 30% Salicylic Acid Peels + 4% Hydroquinone Cream Subjects randomized to have the right side of the face peeled with salicylic acid every 2 weeks for a total of 4 peels (first 2 at 20% and last 2 at 30%). Subjects will apply 4% hydroquinone cream to affected areas on entire face for 14 weeks. | 20 |
| Total | 20 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Withdrawal by Subject | 2 |
Baseline characteristics
| Characteristic | 20% to 30% Salicylic Acid Peels + 4% Hydroquinone Cream |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 0 Participants |
| Age, Categorical Between 18 and 65 years | 20 Participants |
| Age, Continuous | 54 years STANDARD_DEVIATION 6 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 20 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 20 Participants |
| Region of Enrollment United States | 20 participants |
| Sex: Female, Male Female | 20 Participants |
| Sex: Female, Male Male | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 20 |
| other Total, other adverse events | 4 / 20 |
| serious Total, serious adverse events | 0 / 20 |
Outcome results
Number of Participants Showing Improvement of Melasma Based on Mexameter Readings
Improvement of melasma on the peel side using mexameter reading
Time frame: 14 weeks
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| 20% to 30% Salicylic Acid Peels + 4% Hydroquinone Cream | Number of Participants Showing Improvement of Melasma Based on Mexameter Readings | 18 participants |